As AAM journeys across the country with our Generics Are the Solution (GATS) tour, we pay a visit to Teva Pharmaceuticals USA, Inc. in Parsippany, NJ. The Teva team shares with us their commitment to patient access, safety, quality and affordability. “When a generic company wins a patent litigation, it’s like David beating Goliath. The little guy wins. And what that translates to is lower healthcare costs for our patients” says Colman Ragan, Vice President & General Counsel, North America IP Litigation at Teva Pharmaceuticals.
To learn more about the generic and biosimilar medicines industry, visit https://accessiblemeds.org.
